Aurous healthcare

Corporate Profile

AHC is, a rapidly growing comprehensive Contract Research Organization (CRO) built by a dedicated team having diverse talents and expertise to provide health care services in strategic and innovative ways.

We facilitate the needs of Pharmaceutical, Medical Device and Biotechnology organizations worldwide in the area of Drug Discovery and Development. Our collaborative approach and extensive partnerships allow us to understand needs, share ideas, and leverage resources to the benefit of our clients.

We proudly deem that our proven track record of clinical trials, medical writing, Drug discovery and development, pre-clinical trials and Hospital based Bioequivalent trials in the province of Clinical Research as our core strength.

We have partnered with German GLP and Indian GLP accredited animal laboratories for the preclinical research and USFDA approved bio-analytical lab for the relevant needs.

We are the first CRO from Tamilnadu to register clinical trials with the Clinical Trial Registry India (CTRI) of ICMR, Ministry of Health, India and WHO.

Profile

AHC was established in mid 2008, by a small team of technocrats with a focus on phase trials, medical writing, and regulatory coordination to meet the ever growing demand in the field of drug discovery and development. We are proud to declare that, we have attained a remarkable growth in a very short span of time. Eventually, we decided to expand our services and hence included drug development, SMO services, and many more, imparting excellence in our work process everywhere.

Our Growth Quotient

Our technical expertise coupled with our unique business model, allows for quality driven management of projects, exclusively End to End (E-E) trials. AHC has grown from strength to strength, as evident from our portfolio and the repeated, continual patronage from our clients.

Corporate Mile Stones

  • In Sep 2008, AHC commenced its operation on Data Management support services with two staff members.
  • In May 2009, we initiated our first clinical trial.
  • In July 2009, we began drug discovery and development projects for few fixed dose combinations.
  • In March 2010, we began our first animal trial on an ophthalmic formulation.
  • In May 2010, as a mark of quality, AHC was certified by ISO 9001:2015.
  • In June 2011, AHC stretched its boundaries further by establishing a chain of dental clinics called AURO DENTAL CARE.
  • In Nov 2011, AHC established its educational unit, AURO ACADEMY OF EDUCATION & RESEARCH, to hone aspiring minds, as we consider human resource as the backbone of our country.

News

News

  • Article in The Hindu - BUSINESS LINE (March 10, 2014; Pg 18) detailing about R & D partnership of Aurous Healthcare for one of our primordial client- Dhathri Group Readmore..
  • “Article in Deccan Chronicle Chennai (04-Aug-13 Pg26) on the health benefits of Collagen Peptide by Dr. VT.Sriraam” Download Article

  • Public awareness article written by our Managing Director Dr. V. T. Sriraam, M.B.B.S, M.D. published in Tamil Daily "Thinathanthi" on 03-Feb-13. Download Article

  • We are awarded as “The most promising Healthcare R&D Company from Chennai, Tamil Nadu” by BIG research, a brand finding organization from Delhi with its media PartnerNDTV Profit.
    You tube Link: http://youtu.be/eMW1VeSzp2M

  • For the first time in the arena of Clinical Research Academy of India, our academic division “Auro Academy of Education and Research” launches a course in clinical research “Fellowship in Clinical Research Management” with 100% Job Guarantee (14 months work experience as CRA/CRC in our CRO).
    Link: http://auroushealthcare.com/pdf/AAER%20BROCHURE.pdf

  • We have set records in successful completion of two phase III trials on Osteoarthritis on collagen peptide, undertaken from an Indo Japan client and the product Gelixer has got launched successfully into the market
    Link: :http://www.gelixer.com/medical_professionals.asp http://www.youtube.com/watch?feature=player_embedded&v=YoybGsbsQno#!

  • Undertaking of a drug discovery and drug development – End to End project: We have successfully completed formulation and development and animal studies of a FDC (Fixed dose combination) project in Ophthalmology for an Indo MNC. Clinical trial is to be commenced shortly.

  • Ongoing clinical trial projects:
    • Phase III b trial on Osteoporosis
    • Phase III b trial on Dysmennorrhea
    • Dermatological trial on coloring agents
    • 6 Phase IV trials on herbal cosmeceuticals

  • We have completed a two animal toxicity study for FDC (fixed dose combination) in ophthalmology.

  • We have successfully completed the 2nd Surveillance Audit for ISO 9001:2015 certification for Quality Management System.

  • Our Medical Director, DR. V.T. Sriraam, M.D (Pharmacology), has presented a topic in 2011 International Conference on Food Factors on RCT to prove effectiveness and safety of Colla Pep JP and Colla Pep PU dated Nov 20-23, 2011, Taiwan.
    Link :http://www.icoff2011.org/SponsorSessionSpeakers.html

  • Presently, we are undertaking 12 end to end clinical trial managementing various therapeutic areas for Indian, Malaysian and Japanese based MNC.

Our Services

Embroidered Devil Eyes
Spring Embroidery
Geometrical Embroidery
Elephant with Luck
Lady in Red
Fireworks Embroidery Art
Fireworks Embroidery Art

Vision and Mission

Vision
To become the world’s premier quality driven organization in the field of clinical research..Readmore

News and Downloads

Article in Deccan Chronicle Chennai (04-Aug-13 Pg26) on the health benefits..Readmore

Accreditation

ISO Certificate
We have successfully completed the2nd Surveillance Audit for ISO 9001:2015Download

Corporate Brochure

No matter what the scope of the activity, our approach remains consistent. Quality Wins!..Download